Approval · Notice of Compliance 8930 · 2007
PREXIGE: Notice of Compliance 8930
Issued July 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8930
- Date
- July 23, 2007
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the treatment of signs and symptoms of osteoarthritis in adults
- Therapeutic class
- Nonsteroidal anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREXIGE | Not yet assigned | — |
Medicinal ingredients
- LUMIRACOXIB 100 MG per TAB